ARTICLES BY KEVIN BLIGHE
-
![Professional healthcare worker-GettyImages-2167825695]( "Unlocking The Value Of Real-World Data In Global Clinical Trials")
6/5/2026Global real-world data can accelerate trials or quietly distort forecasts, inventory strategy, and regulatory decisions across clinical supply operations.
-
![Rio de Janeiro port-GettyImages-155394827]( "Blind Spots And Blocked Ports: Surviving Clinical Supply Friction In LATAM And APAC")
5/18/2026Clinical trials in LATAM and APAC face hidden supply and data friction as customs, regulations, and IT barriers disrupt forecasting, logistics, and study integrity.
-
![scientific laboratory, medicines, vaccines, pharmaceutical products-GettyImages-2193391324]( "The Atlantic Divide: Forcing FDA Demographics Onto European Supply Chains")
5/8/2026FDA demographic mandates can upend global trial supply, stranding inventory, driving panic packaging, and creating hidden bias that undermines study execution.
Kevin Blighe, Ph.D.
Kevin Blighe, Ph.D., is a consultant statistician bridging the critical gap between complex data architecture and clinical trial execution. While widely recognized for his contributions to bioinformatics, computational biology, and data science, his day-to-day expertise focuses on clinical trial statistics and regulatory strategy across European and U.S. markets. He routinely designs multi-country statistical analysis plans (SAPs), conducts rigorous power analyses, and leads complex FDA pre-submissions (including 510(k)s and INDs) for international medtech and pharma companies. Passionate about cross-functional operational alignment, Kevin advocates for integrating strict statistical theory with ground-level clinical supply logistics to ensure trial success. Connect with Kevin on LinkedIn.